Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Goodwill & Intangibles (2017 - 2025)

Historic Goodwill & Intangibles for Ptc Therapeutics (PTCT) over the last 9 years, with Q3 2025 value amounting to $478.8 million.

  • Ptc Therapeutics' Goodwill & Intangibles rose 1601.56% to $478.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $478.8 million, marking a year-over-year increase of 1601.56%. This contributed to the annual value of $201.1 million for FY2024, which is 5644.9% down from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Goodwill & Intangibles is $478.8 million, which was up 1601.56% from $226.1 million recorded in Q2 2025.
  • Ptc Therapeutics' Goodwill & Intangibles' 5-year high stood at $846.0 million during Q1 2022, with a 5-year trough of $200.8 million in Q1 2025.
  • In the last 5 years, Ptc Therapeutics' Goodwill & Intangibles had a median value of $534.0 million in 2023 and averaged $585.8 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 5644.9% in 2024, then surged by 1601.56% in 2025.
  • Ptc Therapeutics' Goodwill & Intangibles (Quarter) stood at $807.2 million in 2021, then dropped by 2.35% to $788.2 million in 2022, then plummeted by 41.41% to $461.8 million in 2023, then tumbled by 56.45% to $201.1 million in 2024, then surged by 138.05% to $478.8 million in 2025.
  • Its last three reported values are $478.8 million in Q3 2025, $226.1 million for Q2 2025, and $200.8 million during Q1 2025.